142 related articles for article (PubMed ID: 35084232)
21. Apparent diffusion coefficient measurements as very early predictive markers of response to chemotherapy in hepatic metastasis: a preliminary investigation of reproducibility and diagnostic value.
Deckers F; De Foer B; Van Mieghem F; Botelberge T; Weytjens R; Padhani A; Pouillon M
J Magn Reson Imaging; 2014 Aug; 40(2):448-56. PubMed ID: 24924334
[TBL] [Abstract][Full Text] [Related]
22. Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study.
Gültekin MA; Türk HM; Beşiroğlu M; Toprak H; Yurtsever I; Yilmaz TF; Sharifov R; Uysal Ö
Eur J Radiol; 2020 Apr; 125():108895. PubMed ID: 32109834
[TBL] [Abstract][Full Text] [Related]
23. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.
Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A
Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867
[TBL] [Abstract][Full Text] [Related]
24. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
Li X; Zhang K; Shi Y; Wang F; Meng X
J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
[TBL] [Abstract][Full Text] [Related]
25. MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases.
Zhang H; Li W; Hu F; Sun Y; Hu T; Tong T
Abdom Radiol (NY); 2019 Jan; 44(1):65-71. PubMed ID: 29967982
[TBL] [Abstract][Full Text] [Related]
26. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases.
Cui Y; Zhang XP; Sun YS; Tang L; Shen L
Radiology; 2008 Sep; 248(3):894-900. PubMed ID: 18710982
[TBL] [Abstract][Full Text] [Related]
27. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
[TBL] [Abstract][Full Text] [Related]
28. Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
Yu MH; Lee JM; Hur BY; Kim TY; Jeong SY; Yi NJ; Suh KS; Han JK; Choi BI
Eur Radiol; 2015 Aug; 25(8):2428-36. PubMed ID: 25899413
[TBL] [Abstract][Full Text] [Related]
29. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients.
Koh DM; Scurr E; Collins D; Kanber B; Norman A; Leach MO; Husband JE
AJR Am J Roentgenol; 2007 Apr; 188(4):1001-8. PubMed ID: 17377036
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of ADC measurements in predicting overall survival in patients undergoing
Alis D; Durmaz ESM; Gulsen F; Bas A; Kabasakal L; Sager S; Numan F
Clin Imaging; 2019; 57():124-130. PubMed ID: 31220677
[TBL] [Abstract][Full Text] [Related]
31. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
[TBL] [Abstract][Full Text] [Related]
32. Changes in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection.
Chen J; Chen Q; Yao J; Jiang Y; Zhou J; Zhao H; Cai J
Ann Palliat Med; 2021 Oct; 10(10):10276-10292. PubMed ID: 34551571
[TBL] [Abstract][Full Text] [Related]
33. Intra- and interobserver variability of whole-tumour apparent diffusion coefficient measurements in nephroblastoma: a pilot study.
Littooij AS; Humphries PD; Olsen ØE
Pediatr Radiol; 2015 Oct; 45(11):1651-60. PubMed ID: 25951925
[TBL] [Abstract][Full Text] [Related]
34. Diffusion-weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastases.
Mungai F; Pasquinelli F; Mazzoni LN; Virgili G; Ragozzino A; Quaia E; Morana G; Giovagnoni A; Grazioli L; Colagrande S
Radiol Med; 2014 Aug; 119(8):625-33. PubMed ID: 24408046
[TBL] [Abstract][Full Text] [Related]
35. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
[TBL] [Abstract][Full Text] [Related]
36. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging.
Marugami N; Tanaka T; Kitano S; Hirohashi S; Nishiofuku H; Takahashi A; Sakaguchi H; Matsuoka M; Otsuji T; Takahama J; Higashiura W; Kichikawa K
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):638-46. PubMed ID: 19238482
[TBL] [Abstract][Full Text] [Related]
37. Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemotherapy.
Zhu HB; Xu D; Zhang XY; Li XT; Xing BC; Sun YS
Ann Surg Oncol; 2022 Jun; 29(6):3938-3949. PubMed ID: 35013857
[TBL] [Abstract][Full Text] [Related]
38. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.
Fouladi DF; Zarghampour M; Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Khoshpouri P; Kamel IR
Eur Radiol; 2020 Jan; 30(1):291-300. PubMed ID: 31209620
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of diffusion-weighted magnetic resonance imaging in evaluation of early therapeutic response after CT-guided microwave ablation of inoperable lung neoplasms.
Vogl TJ; Emara EH; Elhawash E; Naguib NNN; Aboelezz MO; Abdelrahman HM; Saber S; Nour-Eldin NA
Eur Radiol; 2022 May; 32(5):3288-3296. PubMed ID: 34797384
[TBL] [Abstract][Full Text] [Related]
40. Prediction of Early Response to Chemotherapy in Breast Cancer Liver Metastases by Diffusion-Weighted MR Imaging.
Bai G; Wang Y; Zhu Y; Guo L
Technol Cancer Res Treat; 2019 Jan; 18():1533033819842944. PubMed ID: 30961445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]